WPRIM Management System> DCMS> Chinese Journal of Laboratory Medicine> 2020> 43> 2

Volume: 43 Issue: 2

1. Circulating tumor DNA analysis:from discovery to clinical practice Page:101—104
2. Screening strategy and clinical validation of extracellular vesicle biomarkers Page:105—110
3. Circulating tumor cell detection approaching to clinical application Page:111—114
4. How far is the clinical application of EVs-based tumor diagnosis? Page:115—119
5. Quality control of pre-analytical processes for ctDNA analysis Page:120—123
6. Progress in the application of novel liquid biopsy techniques in clinical tumor diagnosis and treatment Page:124—129
7. Chinese expert consensus on biomarkers for heart failure Page:130—141
8. Expression level and clinical significance of serum exosomal miR-744-5p in non-small cell lung cancer Page:142—146
9. The value of the Luminex magnetic bead immunoassay in detecting serum MBL in kidney transplantation patients Page:147—152
10. Interfering effect of maternal cell contamination on invasive prenatal chromosome microarray analysis Page:153—159
11. Relationship between apolipoprotein E gene polymorphism and cerebral infraction in Chinese type 2 diabetes mellitus patients Page:160—164
12. The alterations and clinical significance of serum S100A8/A9 and sRAGE in patients with chronic obstructive pulmonary disease Page:165—170
13. Retrospective analysis of a ten-year screening project for G6PD deficiency in neonates in Hainan Province Page:171—174
14. Analysis of gut microbiota change in colorectal adenomatous polyps patients by 16S rRNA sequencing Page:175—181
15. Comparison of four screening methods for group B streptococcus Page:182—185
16. Investigation on hemolysis, resistance and homology of Staphylococcus cohnii urealyticum Page:186—190
17. Promoter methylation of SREBP-2 in circulating leukocytes correlates with relevant risk factors in patients with coronary artery disease Page:191—198
18. Research status and progress of Glypican-3 and liver carcinoma Page:199—202
19. Interfering effect of maternal cell contamination on invasive prenatal chromosome microarray analysis Page:153—159
20. Research status and progress of Glypican-3 and liver carcinoma Page:199—202
21. Analysis of gut microbiota change in colorectal adenomatous polyps patients by 16S rRNA sequencing Page:175—181
22. Screening strategy and clinical validation of extracellular vesicle biomarkers Page:105—110
23. Expression level and clinical significance of serum exosomal miR-744-5p in non-small cell lung cancer Page:142—146
24. Circulating tumor cell detection approaching to clinical application Page:111—114
25. Comparison of four screening methods for group B streptococcus Page:182—185
26. Quality control of pre-analytical processes for ctDNA analysis Page:120—123
27. Promoter methylation of SREBP-2 in circulating leukocytes correlates with relevant risk factors in patients with coronary artery disease Page:191—198
28. The alterations and clinical significance of serum S100A8/A9 and sRAGE in patients with chronic obstructive pulmonary disease Page:165—170
29. Retrospective analysis of a ten-year screening project for G6PD deficiency in neonates in Hainan Province Page:171—174
30. Investigation on hemolysis, resistance and homology of Staphylococcus cohnii urealyticum Page:186—190
31. How far is the clinical application of EVs-based tumor diagnosis? Page:115—119
32. The value of the Luminex magnetic bead immunoassay in detecting serum MBL in kidney transplantation patients Page:147—152
33. Relationship between apolipoprotein E gene polymorphism and cerebral infraction in Chinese type 2 diabetes mellitus patients Page:160—164
34. Circulating tumor DNA analysis:from discovery to clinical practice Page:101—104